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Calcification is a common feature of advanced atherosclerotic lesions and is a 
clinically significant predictor of cardiovascular events. Coronary calcification is 
more prevalent in men than age-matched women. However, atherosclerotic 
calcification increases in postmenopausal women, who present with lower levels 
of estrogen, suggesting that sex hormones play a critical role in its pathogenesis 
and progression. This has implications for hormone therapy treatment that is 
used to treat age-related conditions such as osteoporosis and menopause 
Extensive observational studies into estrogen replacement therapy have 
revealed that postmenopausal women treated with estrogen exhibit less 
extensive atherosclerotic calcification. The effects of androgens on 
atherosclerotic calcification have, however, received little attention and 
consequently its mechanisms remain poorly understood. This study therefore 
explored the effects of androgens on atherosclerotic calcification. 
In vitro studies postulate vascular smooth muscle cell (VSMC) differentiation into 
mineralising osteoblast-like cells as a key mediator of atherosclerotic 
calcification. Given the gender disparity in atherosclerot ic calcification we 
hypothesised that androgens promote differentiation of VSMC into mineralising 
osteoblast-like cells. Therefore, the aims of th is study were to 1) examine the 
effects of androgens in vascular smooth muscle cell differentiation and 
calcification and 2) elucidate the molecular mechanisms of androgen action in 
this process, using phosphate-induced bovine and murine in vitro models of 
calcification. 
This study demonstrated that co-treatment of bovine coronary artery smooth 
muscle cells (BCASMC) with phosphate and testosterone (T) and 
dihydrotestosterone (DHT) promoted calcification. Investigation of the 
molecular mechanisms underlying calcification in the bovine model revealed T-
stimulated calcification was estrogen receptor (ER) driven. DHT, however, 
mediated its effects via the androgen receptor (AR). Further investigation of 
molecular mechanisms showed DHT regulated ALP activity whereas T did not. T, 
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therefore, promoted calcification in an ER-driven, ALP independent pathway in 
contrast to DHT, which mediated its effects via an AR-driven, ALP dependent 
pathway. 
A primary mouse cell-based calcification model was also established. In contrast 
to the bovine model, it was found that T and DHT treatment did not promote 
calcification in the murine model. The lack of androgen promotion of 
calcification in this model was associated with the absence of ALP activity. The 
conclusion drawn from the bovine model, of a mechanistic role for ALP in the 
DHT /AR driven mineralisation but not for T-driven mineralisation, suggested 
that in the murine cells an ER pathway is not functioning. 
In conclusion, the studies presented in this thesis demonstrate that T and DHT 
promote differentiation of vascular smooth muscle cells into osteoblast-like cells 
capable of mineralisation. T and DHT mediate calcification via alternative 
pathways that can involve AR and ERs. A potential mechanistic role for ALP in 
DHT /AR-driven mineralisation has been established. 
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